BioRestorative Therapies vs YD Bio
BRTX and YDES side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRTX and YDES compare
YD Bio grew revenue faster over the last twelve months (16.9% versus −8.5% for BioRestorative Therapies).
YD Bio keeps more of each dollar of sales as profit, with a net margin of −1393% compared with −3090% at BioRestorative Therapies.
BioRestorative Therapies scores higher on the StockData Score (8 against 5 for YD Bio), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRTX | YDES |
|---|---|---|
| Size and price | ||
| Market cap | $38.0M | – |
| Share price | $1.49 | $4.88 |
| Change, 1 year | −94.6% | −44.8% |
| Change, 5 years | −98.9% | −52.0% |
| Beta (5Y) | 1.07 | 0.10 |
| Employees | 14 | 13 |
| StockData Score | ||
| Total score | 8 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 106× | – |
| P/B | 12.5× | – |
| Growth | ||
| Revenue growth (TTM) | −8.5% | 16.9% (better) |
| Revenue growth, 5Y average | 36.1% | – |
| Profitability | ||
| Gross margin | 92.1% (better) | 28.1% |
| Operating margin | −3975% | −883% (better) |
| Net margin | −3090% | −1393% (better) |
| FCF margin | – | −1347% |
| Return on equity | −241% | −174% (better) |
| Return on invested capital | – | −130% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.35 | 5.23 (better) |
| Altman Z-score | −47.28 | – |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 0.52% | – |
| Held by insiders | 9.6% | 92.8% |
| Insider net buying, 12 months | – | $129K |
| Short interest, % of float | 0.16% | – |
Go deeper
- BRTX stock overview
- BRTX income statement
- BRTX valuation and score
- YDES stock overview
- YDES income statement
- YDES valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.